Involvement of nuclear receptor RZR/RORγ in melatonin-induced HIF-1α inactivation in SGC-7901 human gastric cancer cells

Oncology Reports

Volumn 34, Issue 5, 2015, Pages 2541-2546

  Wang, Ri Xiong ^a   Liu, Hui ^a,b   Xu, Li ^a,b   Zhang, Hui ^a,b   Zhou, Rui Xiang ^a,b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Gastric cancer; Hypoxia inducible factor 1 ; Melatonin; Nuclear receptor RZR ROR ; SUMOspecific protease 1; Vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MELATONIN; MESSENGER RNA; NUCLEAR RECEPTOR RZR ROR GAMMA; ORPHAN NUCLEAR RECEPTOR; SUMO PROTEIN; SUMO SPECIFIC PROTEASE 1; UNCLASSIFIED DRUG; VASCULOTROPIN; HIF1A PROTEIN, HUMAN; PROTEINASE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; SENP1 PROTEIN, HUMAN; VASCULOTROPIN A;

ARTICLE; BIOACCUMULATION; CANCER CELL; CELL HYPOXIA; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GASTRIC CANCER CELL; HORMONE ACTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; TUMOR VASCULARIZATION; CELL SURVIVAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE;

CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENDOPEPTIDASES; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MELATONIN; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84941945685     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4238     Document Type: Article

References (35)

1. Höckel M and Vaupel P: Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93: 266-276, 2001.
2. Briançon-Marjollet A, Pépin JL, Weiss JW, Lévy P and Tamisier R: Intermittent hypoxia upregulates serum VEGF. Sleep Med 15: 1425-1426, 2014.
3. Ziche M and Gullino PM: Angiogenesis and neoplastic progression in vitro. J Natl Cancer Inst 69: 483-487, 1982.
4. Langsenlehner U, Hofmann G, Renner W, Gerger A, Krenn-Pilko S, Thurner EM, Krippl P and Langsenlehner T: Association of vascular endothelial growth factor - a gene polymorphisms and haplotypes with breast cancer metastases. Acta Oncol 54: 368-376, 2015.
5. Semenza GL: Intratumoral hypoxia, radiation resistance, and HIF-1. Cancer Cell 5: 405-406, 2004.
6. Lara PC, Lloret M, Clavo B, Apolinario RM, Henríquez-Hernández LA, Bordón E, Fontes F and Rey A: Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression. Radiat Oncol 4: 29, 2009.
7. Ratcliffe PJ, O'Rourke JF, Maxwell PH and Pugh CW: Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201: 1153-1162, 1998.
8. Srinivas V, Zhang LP, Zhu XH and Caro J: Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins. Biochem Biophys Res Commun 260: 557-561, 1999.
9. Reddy KR, Guan Y, Qin G, Zhou Z and Jing N: Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy. Prostate 71: 1796-1809, 2011.
10. Warfel NA and El-Deiry WS: HIF-1 signaling in drug resistance to chemotherapy. Curr Med Chem 21: 3021-3028, 2014.
11. Noche RR, Lu PN, Goldstein-Kral L, Glasgow E and Liang JO: Circadian rhythms in the pineal organ persist in zebrafish larvae that lack ventral brain. BMC Neurosci 12: 7, 2011.
12. León J, Casado J, Jiménez Ruiz SM, Zurita MS, González-Puga C, Rejón JD, Gila A, Muñoz de Rueda P, Pavón EJ, Reiter RJ, et al: Melatonin reduces endothelin-1 expression and secretion in colon cancer cells through the inactivation of FoxO-1 and NF-κβ. J Pineal Res 56: 415-426, 2014.
13. Yang Y, Sun Y, Yi W, Li Y, Fan C, Xin Z, Jiang S, Di S, Qu Y, Reiter RJ, et al: A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases. J Pineal Res 57: 357-366, 2014.
14. Lopes JR, Maschio LB, Jardim-Perassi BV, Moschetta MG, Ferreira LC, Martins GR, Gelaleti GB and De Campos Zuccari DA: Evaluation of melatonin treatment in primary culture of canine mammary tumors. Oncol Rep 33: 311-319, 2015.
15. Cutando A, Aneiros-Fernández J, López-Valverde A, Arias-Santiago S, Aneiros-Cachaza J and Reiter RJ: A new perspective in oral health: Potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity. Arch Oral Biol 56: 944-950, 2011.
16. Carocci A, Catalano A and Sinicropi MS: Melatonergic drugs in development. Clin Pharmacol 6: 127-137, 2014.
17. Wiesenberg I, Missbach M and Carlberg C: The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 12: 143-150, 1998.
18. Ekmekcioglu C: Melatonin receptors in humans: Biological role and clinical relevance. Biomed Pharmacother 60: 97-108, 2006.
19. Karamitri A, Vincens M, Chen M and Jockers R: Involvement of melatonin MT2 receptor mutants in type 2 diabetes development. Med Sci 29: 778-784, 2013 (In French).
20. Karasek M, Carrillo-Vico A, Guerrero JM, Winczyk K and Pawlikowski M: Expression of melatonin MT(1) and MT(2) receptors, and ROR alpha(1) receptor in transplantable murine Colon 38 cancer. Neuro Endocrinol Lett 23 (Suppl 1): 55-60, 2002.
21. Winczyk K, Pawlikowski M, Guerrero JM and Karasek M: Possible involvement of the nuclear RZR/ROR-alpha receptor in the antitumor action of melatonin on murine Colon 38 cancer. Tumour Biol 23: 298-302, 2002.
22. Cho SY, Lee HJ, Jeong SJ, Lee HJ, Kim HS, Chen CY, Lee EO and Kim SH: Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells. J Pineal Res 51: 87-93, 2011.
23. Zhang Y, Liu Q, Wang F, Ling EA, Liu S, Wang L, Yang Y, Yao L, Chen X, Wang F, et al: Melatonin antagonizes hypoxiamediated glioblastoma cell migration and invasion via inhibition of HIF-1α. J Pineal Res 55: 121-130, 2013.
24. Paroni R, Terraneo L, Bonomini F, Finati E, Virgili E, Bianciardi P, Favero G, Fraschini F, Reiter RJ, Rezzani R, et al: Antitumour activity of melatonin in a mouse model of human prostate cancer: Relationship with hypoxia signalling. J Pineal Res 57: 43-52, 2014.
25. Yang L, Zheng J, Xu R, Zhang Y, Gu L, Dong J, Zhu Y, Zhou R, Zheng L, Zhang X, et al: Melatonin suppresses hypoxia-induced migration of HUVECs via inhibition of ERK/Rac1 activation. Int J Mol Sci 15: 14102-14121, 2014.
26. Liu H, Xu L, Wei JE, Xie MR, Wang SE and Zhou RX: Role of CD4+ CD25+ regulatory T cells in melatonin-mediated inhibition of murine gastric cancer cell growth in vivo and in vitro. Anat Rec 294: 781-788, 2011.
27. Xu L, Liu H, Zhang H, Wang RX, Song J and Zhou RX: Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism. Anat Rec 296: 914-920, 2013.
28. Ye LY, Zhang Q, Bai XL, Pankaj P, Hu QD and Liang TB: Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: A meta-analysis. Pancreatology 14: 391-397, 2014.
29. García JJ, López-Pingarrón L, Almeida-Souza P, Tres A, Escudero P, García-Gil FA, Tan DX, Reiter RJ, Ramírez JM and Bernal-Pérez M: Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: A review. J Pineal Res 56: 225-237, 2014.
30. Carlberg C and Wiesenberg I: The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: An unexpected relationship. J Pineal Res 18: 171-178, 1995.
31. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, Yoo MA, Song EJ, Lee KJ and Kim KW: Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111: 709-720, 2002.
32. Geoffroy MC and Hay RT: An additional role for SUMO in ubiquitin-mediated proteolysis. Nat Rev Mol Cell Biol 10: 564-568, 2009.
33. Wang Q, Xia N, Li T, Xu Y, Zou Y, Zuo Y, Fan Q, Bawa-Khalfe T, Yeh ET and Cheng J: SUMO-specific protease 1 promotes prostate cancer progression and metastasis. Oncogene 32: 2493-2498, 2013.
34. Gu J, Fan Y, Liu X, Zhou L, Cheng J, Cai R and Xue S: SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway. Cardiovasc Res 104: 83-92, 2014.
35. Park SY, Jang WJ, Yi EY, Jang JY, Jung Y, Jeong JW and Kim YJ: Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res 48: 178-184, 2010.